According to the latest market study by MarkNtel Advisors titled “Global Solid Tumor Testing Market Size, Share, Trends, Growth, Opportunity Analysis 2023-2028” presents a thorough examination of market drivers, opportunities and challenges.

Utilizing a quantitative approach, it offers precise insights into market size, share, and growth. Crafted by industry experts, the report delves into consumption patterns, geographical analysis, and competitive landscapes. Its objective is to furnish valuable insights for clients seeking to comprehend and leverage market dynamics. With a dual focus on historical achievements and future projections, it furnishes a nuanced understanding of the market terrain.

The Global Solid Tumor Testing Market size is projected to grow at a CAGR of around 8.0% during the forecast period, 2023-28.

In case you missed it, we are currently revising our reports. Click on the "request sample report" button to get the latest research data with forecast for the years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn't take long for the team to deliver the most recent version of the report.

Rising Adoption of Next-generation sequencing (NGS) technique in Solid Tumor Testing – Next-generation sequencing (NGS) is a technique used to analyze multiple genomes at a time. The growing incidence of chronic & life-threatening diseases like cancer demands fast & precise testing results for patient treatment. NGS technique also permits the technician to analyze epigenetic factors such as genome-wide DNA methylation & DNA-protein interactions, utilize RNA sequencing (RNA-Seq) to discover novel RNA variants & splice sites, and quantify mRNAs for gene expression analysis. All these factors result in an increased adoption rate of the NGS technique.

This report focuses on major market participants like:

• Abbott Laboratories
• ARUP Laboratories
• ASURAGEN, INC.
• Bio-Rad Laboratories, Inc
• Beijing Genomics Institute (BGI) Genomics Co., Ltd
• Hoffmann-La Roche Ltd
• Guardant Health
• Illumina, Inc.
• Invivoscribe, Inc.
• Invitae Corporation
• Laboratory Corporation of America Holdings
• NeoGenomics Laboratories, Inc.
• Opko Health
• OmniSeq
• QIAGEN N.V
• Quest Diagnostics Inc
• Others

Explore Our Comprehensive Study: https://www.marknteladvisors.com/research-library/solid-tumor-testing-market.html

This segmentation analysis outlines prominent sections in the report's table of contents. Each segment undergoes thorough analysis, including sub-segments, to showcase both current and historical market sizes. The analysis underscores investment opportunities for rapid growth, particularly in the Solid Tumor Testing Market, with notable highlighting on:

-By End Users

• Hospitals, Diagnostic Laboratories, and Reference Laboratories
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Academic Research Institutions

Of them all, Hospitals, Diagnostic Laboratories, and Reference Laboratories, collectively forming the clinical sector, are at the forefront of adopting solid tumor testing services into routine healthcare procedures. Clinical services have incorporated an extensive molecular diagnostics portfolio to deliver superior care to patients, not just for routine diagnostic procedures but also to assess biomarker levels during hospital stays with treatment dissemination.

-By Cancer Type

• Prostate Cancer
• Breast Cancer
• Colorectal Cancer
• Endometrial Cancer
• Melanoma
• Lung Cancer
• Thyroid Cancer
• Brain Cancer
• Ovarian Cancer
• Liver Cancer
• Other Cancer Types

-By Application

• Clinical
• Research

-By Technologies

• In Situ Hybridization
• Immunohistochemistry
• Polymerase Chain Reaction
• Next-Generation Sequencing
• Other Technologies (Microarray, ELISA, and LC/MS)

• North America
• South America
• Europe
• Middle East & Africa
• Asia Pacific

 Get Customized Reports As Per Your Requirements: https://www.marknteladvisors.com/query/request-customization/solid-tumor-testing-market.html

• Factors Driving Market Growth: Understand the primary drivers propelling the Solid Tumor Testing market forward.
• Access to Reliable Reports: Learn where to access dependable market reports for informed decision-making.
• Growth Projections: Gain insights into anticipated growth projections for the coming years.
• Geographical Hotspots: Identify geographical poised for significant market growth soon.

MarkNtel Advisors is a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 14.8 diverse industrial verticals.

Media Representative

Company Name: MarkNtel Advisors

Email: sales@marknteladvisors.com 

Phone: +1 628 895 8081, +91 120 4278433